Antitumor, immunomodulatory and anti-HIV effect of mangiferin, a naturally occurring glucosylxanthone

Chemotherapy. 1996 Nov-Dec;42(6):443-51. doi: 10.1159/000239478.


Mangiferin, a C-glucosylxanthone (1,3,6,7-tetrahydroxyxanthone-C2-beta-D-glucoside) purified from plant sources was shown to have in vivo growth-inhibitory activity against ascitic fibrosarcoma in Swiss mice. Following in vivo or in vitro treatment, it also enhanced tumor cell cytotoxicity of the splenic cells and peritoneal macrophages of normal and tumor-bearing mice. In vitro treatment of the splenic cells of tumor-bearing mice with mangiferin resulted in augmented killing of tumor cells, both resistant and sensitive to natural killer cells. Mangiferin was also found to antagonize in vitro the cytopathic effect of HIV. The drug appears to act as a potent biological response modifier with antitumor and antiviral effect.

MeSH terms

  • Adjuvants, Immunologic / therapeutic use*
  • Animals
  • Anti-HIV Agents / therapeutic use*
  • Antibody-Dependent Cell Cytotoxicity / drug effects
  • Antibody-Dependent Cell Cytotoxicity / immunology
  • Antineoplastic Agents / therapeutic use*
  • Fibrosarcoma / drug therapy*
  • HIV Infections / prevention & control*
  • Immunologic Factors / therapeutic use
  • Lymphocytes / drug effects
  • Lymphocytes / immunology
  • Macrophages, Peritoneal / drug effects
  • Macrophages, Peritoneal / immunology
  • Male
  • Mice
  • Mice, Inbred Strains
  • Spleen / drug effects
  • Spleen / immunology
  • Xanthenes / therapeutic use*
  • Xanthones*


  • Adjuvants, Immunologic
  • Anti-HIV Agents
  • Antineoplastic Agents
  • Immunologic Factors
  • Xanthenes
  • Xanthones
  • mangiferin